Bli medlem
Bli medlem

Du är här


DanCann Pharma A/S: CEO Jeppe Krog Rasmussen buys shares in DanCann Pharma A/S

COPENHAGEN, Denmark, 26 February 2021 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company") hereby announce that Jeppe Krog Rasmussen, Founder, Board Member and CEO at DanCann Pharma A/S has privately through his holding company (JKR INVESTMENT GROUP ApS) bought 60,000 shares in DanCann Pharma A/S at an average price of DKK 3.22 per share.

The shares were purchased in the ongoing trading on Spotlight Stock Market on Friday 26 February 2021.

Following this transaction, Jeppe Krog Rasmussen now directly through his holding company (JKR INVESTMENT GROUP ApS) controls 5,340,000 shares, corresponding to approx. 25.76 percent (25.47 percent before) in total at DanCann Pharma.

Jeppe Krog Rasmussen comments:

"I have taken the opportunity to buy and expand my position in DanCann Pharma after a long time without the possibility of trading as one of the people on the permanent insider list at DanCann Pharma. I look very positively at the future of DanCann Pharma and believe a lot in the team and our ongoing projects in the company - we have a very exciting and interesting journey ahead of us," says CEO, Jeppe Krog Rasmussen.

About DanCann Pharma

DanCann Pharma A/S (SS: DANCAN) was founded in 2018 and is a Danish biopharmaceutical company powered by cannabinoids. DanCann Pharma is a vertically integrated, licensed production and distribution company based in Denmark. The company focuses on discovering, developing, manufacturing, and commercializing new therapeutic cannabinoids in a wide range of disease areas.

For further information, please contact:

Jeppe Krog Rasmussen, CEO

Författare Cision